Evaluation of dapsone and its synthetic derivative DDS‑13 in cancer <em>in vitro</em>

Cabral‑Pacheco,Griselda A.; Flores‑Morales,Virginia; Garza‑Veloz,Idalia; Damián‑Sandoval,Miriam; Martínez‑Flores,Rosa B.; Martínez‑Vázquez,María C.; Delgado‑Enciso,Iván; Rodriguez‑Sanchez,Iram P.; Martinez‑Fierro,Margarita L.

doi:10.3892/etm.2023.12335

Evaluation of dapsone and its synthetic derivative DDS‑13 in cancer in vitro

Authors:
- Griselda A. Cabral‑Pacheco
- Virginia Flores‑Morales
- Idalia Garza‑Veloz
- Miriam Damián‑Sandoval
- Rosa B. Martínez‑Flores
- María C. Martínez‑Vázquez
- Iván Delgado‑Enciso
- Iram P. Rodriguez‑Sanchez
- Margarita L. Martinez‑Fierro
View Affiliations

Affiliations: Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico, Laboratory of Asymmetric Synthesis and Bio‑Chemoinformatics, Chemical Engineering, Autonomous University of Zacatecas, Zacatecas 98160, Mexico, School of Medicine, University of Colima, Colima 28040, Mexico, Molecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo Leon, Nuevo León 66455, Mexico
Published online on: December 4, 2023 https://doi.org/10.3892/etm.2023.12335
Article Number: 47
Copyright: © Cabral‑Pacheco et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study highlighted the repositioning of the drug dapsone (DDS) for cancer therapy. Due to its mechanism of action, DDS has a dual effect as an antibiotic and as an anti‑inflammatory/immunomodulator; however, at high doses, it has important adverse effects. The derivative DDS‑13 [N,N'‑(sulfonyl bis (4,1‑phenylene)) dioctanamide] was synthesized through an N‑acylation reaction to compare it with DDS. Its cytotoxic effects in cancer cells (DU145 and HeLa) and non‑cancer cells (HDFa) were observed at concentrations ranging 0.01‑100 µM and its physicochemical/pharmacokinetic properties were analyzed using the SwissADME tool. The objectives of the present study were to evaluate the anticancer activity of both DDS and DDS‑13 and to identify the physicochemical and pharmacokinetic properties of DDS‑13. The results showed that DDS‑13 presented a cytotoxic effect in the DU145 cell line (IC₅₀=19.06 µM), while DDS showed a cytotoxic effect on both the DU145 (IC₅₀=11.11 µM) and HeLa (IC₅₀=13.07 µM) cell lines. DDS‑13 appears to be a good cytotoxic candidate for the treatment of prostate cancer, while DDS appears to be a good candidate for both cervical and prostate cancer. Neither candidate showed a cytotoxic effect in non‑cancerous cells. The different pharmacokinetic properties of DDS‑13 make it a new candidate for evaluation in preclinical models for the treatment of cancer.

View Figures

View References

1	Catherine Sánchez N: Knowing and understanding the cancer cell: physiopathology of cancer. Rev Méd Clin Las Condes. 24:553–562. 2013.
2	World Health Organization (WHO): International Agency for Research on Cancer. WHO, Geneva, 2020. https://gco.iarc.fr/today/online-analysis-multi-bars.
3	Ghose S, Radhakrishnan V and Bhattacharya S: Ethics of cancer care: Beyond biology and medicine. Ecancermedicalscience. 13(911)2019.PubMed/NCBI View Article : Google Scholar
4	Jarada TN, Rokne JG and Alhajj R: A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions. J Cheminform. 12(46)2020.PubMed/NCBI View Article : Google Scholar
5	Ross CM: The treatment of acne vulgaris with dapsone. Br J Dermatol. 73:367–370. 1961.PubMed/NCBI View Article : Google Scholar
6	Reunala T, Hervonen K and Salmi T: Dermatitis herpetiformis: An update on diagnosis and management. Am J Clin Dermatol. 22:329–338. 2021.PubMed/NCBI View Article : Google Scholar
7	Wozel G and Blasum C: Dapsone in dermatology and beyond. Arch Dermatol Res. 306:103–124. 2014.PubMed/NCBI View Article : Google Scholar
8	Molinelli E, Paolinelli M, Campanati A, Brisigotti V and Offidani A: Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone. Expert Opin Drug Metab Toxicol. 15:367–379. 2019.PubMed/NCBI View Article : Google Scholar
9	Boccellino M, Quagliuolo L, Alaia C, Grimaldi A, Addeo R, Nicoletti GF, Kast RE and Caraglia M: The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: From rash mitigation to the increase in anti-tumor activity. Curr Med Res Opin. 32:1839–1848. 2016.PubMed/NCBI View Article : Google Scholar
10	Kanoh S, Tanabe T and Rubin BK: Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret. Chest. 140:980–990. 2011.PubMed/NCBI View Article : Google Scholar
11	Karpel-Massler G, Kast RE, Siegelin MD, Dwucet A, Schneider E, Westhoff MA, Wirtz CR, Chen XY, Halatsch ME and Bolm C: Anti-glioma activity of dapsone and its enhancement by synthetic chemical modification. Neurochemical Res. 42:3382–3389. 2017.PubMed/NCBI View Article : Google Scholar
12	Lindenberg M, Kopp S and Dressman JB: Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 58:265–278. 2004.PubMed/NCBI View Article : Google Scholar
13	Gallardo CA, Fan BE, Lim KGE and Kuperan P: Chronic dapsone use causing methemoglobinemia with oxidative hemolysis and dyserythropoiesis. Am J Hematol. 96:1715–1716. 2021.PubMed/NCBI View Article : Google Scholar
14	Vogel AI, Furniss BS, Hannaford AJ, Smith PW and Tatchell AR: Vogel's textbook of practical organic chemistry. 5th edition. John Wiley & Sons, New York, NY, pp395-469, 1989.
15	Lidstrom P, Tierney J, Wathey B and Westman J: Microwave assisted organic synthesis-a review. Tetrahedron. 57:9225–9283. 2001.
16	Lipinski CA, Lombardo F, Dominy BW and Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46:3–26. 2001.PubMed/NCBI View Article : Google Scholar
17	Ghose AK, Viswanadhan VN and Wendoloski JJ: A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem. 1:55–68. 1999.PubMed/NCBI View Article : Google Scholar
18	Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW and Kopple KD: Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 45:2615–2623. 2002.PubMed/NCBI View Article : Google Scholar
19	Egan WJ, Merz KM Jr and Baldwin JJ: Prediction of drug absorption using multivariate statistics. J Med Chem. 43:3867–3877. 2000.PubMed/NCBI View Article : Google Scholar
20	Muegge I, Heald SL and Brittelli D: Simple selection criteria for drug-like chemical matter. J Med Chem. 44:1841–1846. 2001.PubMed/NCBI View Article : Google Scholar
21	Sathawane P, Kamal MM, Deotale PR and Mankar H: Nuances of the Papanicolaou stain. Cytojournal. 19(43)2022.PubMed/NCBI View Article : Google Scholar
22	Swiss Institute of Bioinformatics (SIB): SwissADME. http://www.swissadme.ch/index.php#.
23	March-Vila E, Pinzi L, Sturm N, Tinivella A, Engkvist O, Chen H and Rastelli G: On the integration of in silico drug design methods for drug repurposing. Front Pharmacol. 8(298)2017.PubMed/NCBI View Article : Google Scholar
24	do Amaral LH, do Carmo FA, Amaro MI, de Sousa VP, da Silva L, de Almeida GS, Rodrigues CR, Healy AM and Cabral LM: Development and characterization of dapsone cocrystal prepared by scalable production methods. AAPS PharmSciTech. 19:2687–2699. 2018.PubMed/NCBI View Article : Google Scholar
25	Jornada DH, dos Santos Fernandes GF, Chiba DE, de Melo TR, dos Santos JL and Chung MC: The prodrug approach: A successful tool for improving drug solubility. Molecules. 21(42)2015.PubMed/NCBI View Article : Google Scholar
26	Day TP, Sil D, Shukla NM, Anbanandam A, Day VW and David SA: Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin. Mol Pharm. 8:297–301. 2011.PubMed/NCBI View Article : Google Scholar
27	Schilder RJ, Sill MW, Lee YC and Mannel R: A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: A gynecologic oncology group study. Int J Gynecol Cancer. 19:929–933. 2009.PubMed/NCBI View Article : Google Scholar
28	Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, et al: Enzalutamide with standard first-line therapy in metastatic prostate cancer. N Engl J Med. 381:121–131. 2019.PubMed/NCBI View Article : Google Scholar
29	Daina A and Zoete V: A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 11:1117–1121. 2016.PubMed/NCBI View Article : Google Scholar
30	Pillai V, Kadu R, Buch L and Singh VK: Derivatives of dapsone (dap): Synthesis and study on in vitro anticancer activity and DNA laddering against Hep G2 and C6 human cancer cell lines. ChemistrySelect. 2:4382–4391. 2017.
31	Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S, Habet SA, Baweja RK, Burckart GJ, et al: New era in drug interaction evaluation: US food and drug administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol. 48:662–670. 2008.PubMed/NCBI View Article : Google Scholar
32	Uetrecht J, Zahid N, Shear NH and Biggar WD: Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells. J Pharmacol Exp Ther. 245:274–279. 1988.PubMed/NCBI
33	Tian D and Hu Z: CYP3A4-mediated pharmacokinetic interactions in cancer therapy. Curr Drug Metab. 15:808–817. 2014.PubMed/NCBI View Article : Google Scholar
34	Guzmán-Ávila R, Avelar M, Márquez EA, Rivera-Leyva JC, Mora JR, Flores-Morales V and Rivera-Islas J: Synthesis, in vitro, and in silico analysis of the antioxidative activity of dapsone imine derivatives. Molecules. 26(5747)2021.PubMed/NCBI View Article : Google Scholar
35	Zasosov VA: Diacyl derivatives of bis (4-aminophenyl) sulfone. Zhurnal Obshchei Khimii. 17:471–476. 1947.
36	Hensel; Walter; Buechner O, inventor Polyolefin molding compositions containing diamides, 1967.